I'm talking about the Greenland shark, currently considered the longest-lived vertebrate, according to genomic & radiocarbon dating. The radiocarbon dating works like this: Between 1952 & 1963, atmospheric nuclear bomb tests released a massive spike of radioactive ¹⁴C into the atmosphere. This spike caused the "bomb pulse." That bomb pulse of carbon entered the ocean, entered plankton, entered fish & ultimatelky entered shark tissues, including the eye lens nucleus. A shark's eye grows like an onion. The innermost layers form before birth; new layers are added outside throughout its long life, but the core never changes. So the core of the shark's eye lens is a time capsule of the shark's birth year. Scientists measured ¹⁴C levels in the eye lens core. If the core contained bomb pulse ¹⁴C, the shark must have been born after 1955, but if the core contained pre-bomb ¹⁴C, the shark must have been born before 1950—possibly centuries earlier. How much older? This is where genetics & growth cycles provide the answers.

Greenland sharks grow very slowly, around 1 cm per year (0.4 in/yr). They mature at around 150 years. This means a Greenland shark is basically a teenager for a century and a half. In biological terms, they don't reproduce until they're about 150 years old. This is the slowest maturation of any vertebrate. At the very minimum, they are at least 200 years old, but likely closer to 400 to possibly 512 years old. Even at 200 years, they are still the oldest vertebrates on Earth, beyond bowhead whales & Galapagos tortoises. Even Jonathan, the famed Galapagos tortoise, is 192-194 years old—the oldest land animal.

Why do they live so long? The genome sequence of the Greenland shark has recently been completed that shows enhanced DNA repair systems. They have robust chromatin organization. Chromatin is the way DNA is packaged, like a bubble wrap for your genome. In Greenland sharks, chromatin stays tightly regulated, preventing DNA from getting tangled or broken. This reduces mutations, the seeds of aging & cancer. They have expanded ferritin genes, the iron-storage genes. Free iron reacts with oxygen to produce free radicals that can damage cells, but the sharks' ferritin is like a safe that locks away iron, preventing cellular damage.

Hope for Pancreatic Cancer: New Drug Darzanbrasib Offers Extended Survival

The Future of Oncology: Targeted Therapies and Your CareerThe emergence of drugs like darzanbrasib signifies a pivotal shift in cancer treatment, pote...

Transforming Farm-Level Performance with Molecular Innovation

The US Animal Genetics Market is fundamentally shifting the way agriculture approaches efficiency and sustainability. By utilizing advanced molecular diagnostics, producers can now make informed decisions that optimize every aspect of the animal lifecycle, from birth to market. As the sector targets a valuation of USD 2,309 Million by 2030, the adoption of these innovative tools is becoming a prerequisite for any operation looking to maintain profitability in an increasingly tech-reliant agricultural sector.

Exploring the Animal Genetics industry

The Animal Genetics industry is undergoing a transformation driven by the need for better integration between diagnostic laboratories and large-scale farming enterprises. This move toward a more cohesive, tech-enabled supply chain is reducing inefficiencies and increasing the speed at which genetic improvements can be realized. By standardizing testing protocols and ensuring seamless data flow, industry leaders are empowering producers to make faster, more accurate decisions that enhance both animal welfare and production quality.

Sustaining the Vision for 2030 Growth

Maintaining the projected growth trajectory requires ongoing investment in both infrastructure and human capital. As the demand for sophisticated genetics continues to rise, the need for skilled geneticists, data scientists, and reproductive specialists will grow accordingly. This professionalization of the workforce is crucial for ensuring that the industry can effectively implement the advanced tools—such as genomic selection and embryo vitrification—that will form the backbone of the next generation of animal agriculture.

Future Perspectives for Regional Leadership

Market Insights

The DNA RNA Protection Reagent Market is experiencing significant growth as advancements in molecular biology, genomics, and life sciences research continue to expand globally. DNA and RNA protection reagents play a critical role in preserving nucleic acid integrity during sample collection, storage, transportation, and analysis. As research institutions, diagnostic laboratories, and biotechnology companies increasingly rely on high-quality biological samples, the demand for reliable preservation solutions is rising across various scientific and clinical applications.

Get More Info:

Growing Importance in Molecular Research

DNA and RNA preservation has become a fundamental requirement in modern biological research and diagnostic testing. Researchers depend on protection reagents to prevent nucleic acid degradation and ensure accurate downstream analysis. The growing use of genomic studies, biomarker discovery, gene expression analysis, and precision medicine initiatives is creating strong demand for effective preservation technologies that maintain sample quality throughout the research process.

Technological Advancements Supporting Market Expansion

Continuous innovation in reagent formulations is improving the effectiveness and stability of nucleic acid preservation solutions. Modern protection reagents are designed to support a wide range of biological samples while offering enhanced storage flexibility and simplified handling procedures. These advancements are enabling laboratories to achieve more reliable results and improve overall workflow efficiency in research and diagnostic applications.

Key Market Drivers

• Rising investment in genomics and molecular biology research • Growing demand for accurate diagnostic and research outcomes • Increasing adoption of precision medicine initiatives • Advancements in nucleic acid preservation technologies • Expanding biotechnology and life sciences industries worldwide

Emerging Opportunities

The market is witnessing new opportunities through the expansion of personalized medicine programs, biobanking activities, and advanced diagnostic testing. Increasing collaborations among research institutions, healthcare organizations, and biotechnology companies are driving the development of innovative preservation solutions. Additionally, the growing emphasis on sample quality and reproducibility is encouraging broader adoption of DNA and RNA protection reagents across diverse applications.

Future Outlook

The DNA RNA Protection Reagent Market is expected to maintain strong growth momentum as scientific research and molecular diagnostics continue to evolve. Increasing demand for high-quality biological samples, ongoing technological advancements, and expanding investments in life sciences research are likely to support long-term market expansion. Organizations that focus on innovation, reliability, and research-driven solutions are expected to strengthen their position in this dynamic market.

Well, to be clear, it was not the original mouse but rather its identical clones. In 2005, Teruhiko Wakayama (Univ. of Yamanashi) cloned a female mouse called Polly using somatic cell nuclear transfer (SCNT). "Somatic" means any body cell (skin cell, blood cell, etc.); "nuclear" means the nucleus, which holds DNA; & "transfer" is moving the nucleus into another cell. Every somatic cell in your body contains your full DNA blueprint. If you put that DNA into an egg cell & start development, the embryo grows using that exact DNA, producing a genetic copy-clone. This is the cloning technique Wakayama used, taking cells from the clone to make another clone & another & another, repeating over 1,200x, producing 58+ generations of serial clones. This is the longest serial cloning experiment ever attempted in mammals.

His team wanted to find out if there is a limit to successful cloning. Much to their surprise, early generations actually had improved embryo development without faults or mutations. The success rate peaked at 215.5% in the 26th generation, but later generations' success rate plummeted to just 0.6% by the 57th/58th generation, basically one good embryo out of 167. This is like photocopying an original 1,000 times. Each round introduces tiny flaws that eventually make the copy unusable. But in biology, the "blurriness" isn't ink fading—it's DNA damage & epigenetic mistakes. Epigenetics decides what a cell should do & how it should behave. It changes with age, stress, diet & environment. In cloning, epigenetic instructions go awry. In cloning, telomeres, the protective shield on cells, shorten & the shorter they get, the more likely cellular damage will occur. The cells' engine, called mitochondria, is prone to wear & tear the more cloning goes on.

In earlier generations of somatic cell nuclear transfer (SCNT), the cloned cells tolerated the transfer well. Epigenetic marks were still relatively intact. Telomeres were still strong enough, & mitrochondria were still functional. But as more & more clones are produced, ad nauseam, each rebuild must first erase & rebuild the epigenome. But after the 26th generation, the wrong instructions accumulate, which confuses the cell about which genes to use, & cloning never fully erases their mistakes. By generation 50+, the epigenome is no longer a clean slate. Embryos fail because the developmental program cannot run. By late generations, the genome behaves like a tired photocopy of a photocopy.

For people hoping to clone their pets, this should serve as a good lesson. There's a limit on how often you can clone your favorite pet. At best, you can clone & reclone your pet maybe twice. You might be wondering why the scientists could successfully reclone Polly 26 times, but you can't. Because they used a special, carefully selected cell line & controlled lab conditions. Pet cloning uses ordinary adult cells from a real animal—which are far more damaged, messy & unpredictable than pristine lab-grown cell lines. There's also the ethical argument of cloning pets given the large number of shelter animals euthanized each year.

72049

🧬 Gene Expression and Transcriptome Sequencing Market Driving Precision Medicine Innovation

The global Gene Expression and Transcriptome Sequencing market is experiencing significant growth as advancements in genomics and next-generation sequencing technologies continue to transform biomedical research and precision healthcare.

Researchers and healthcare organisations are increasingly using transcriptome sequencing to study gene activity, identify disease biomarkers, and develop targeted therapies. The technology plays a critical role in cancer research, drug discovery, genetic disorder analysis, and personalised medicine initiatives.

Key market trends include: ✔️ Rising adoption of next-generation sequencing (NGS) technologies ✔️ Growing focus on precision medicine and personalised healthcare ✔️ Increasing genomic research in oncology and rare diseases ✔️ Advancements in bioinformatics and data analysis platforms ✔️ Expanding investments in biotechnology and life sciences research

The market is also benefiting from improved sequencing accuracy, reduced costs of genomic analysis, and growing collaborations between research institutions and biotech companies. As demand for advanced molecular diagnostics and targeted treatment strategies continues to rise, gene expression and transcriptome sequencing technologies are expected to play a major role in the future of healthcare innovation.

Explore the full report here: Gene Expression and Transcriptome Sequencing Market Report

🧬 Unlocking the Genetic Blueprint of Tomorrow’s Crops

Genetics is transforming the future of agriculture, and innovation begins here! Be part of the Advances in Plant Genetics & Genomics session at the 2nd International Conference on Plant Science and Molecular Biology (IPMB 2026) organized by Inovine Scientific Meetings.

🌍 Discover how next-generation research is reshaping: ✨ Genome exploration ✨ Gene-editing technologies ✨ Climate-resilient crops ✨ Sustainable agricultural solutions ✨ Advanced breeding strategies

📍 Paris, France | 💻 Hybrid Participation 🗓 November 23–24, 2026

🎤 Share your research and connect with an international community of scientists and innovators.

📢 Abstract Submission Open: https://plantscience.inovineconferences.com/submit-abstract.php